Coca-Cola Europacific Partners releases interim 2026 trading update transcript

Reuters2026/08/04 14:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Coca-Cola Europacific Partners published an interim 2026 trading update transcript from a call attended by CEO Damian Gammell, CFO Ed Walker, VP Sarah Willett.
H1 revenue €10.7 billion, up 6.1%; volumes up 6% or 2% days-adjusted; revenue per unit case up 0.4%.
Operating profit €1.5 billion, up 8.1%; operating margin 13.8%, up 30 bps; diluted EPS €2.20, up 10.6%.
Comparable free cash flow €435 million; guidance reaffirmed for at least €1.7 billion for the year; €600 million of €1 billion buyback completed.
Cost of sales per unit case up 0.6% versus ~1.5% full-year view; Middle East-related absorption expected to weigh more in H2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coca-Cola Europacific Partners plc published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经•2026/09/14 00:46

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

Reuters•2026/09/14 00:39

Oman postpones the meeting originally scheduled for the 14th with Iran and other countries; the US warns: Don't expect a breakthrough in the Strait of Hormuz

华尔街见闻•2026/09/14 00:23